Effect of Fenfluramine Challenge on Cocaine Craving in Addicted Male Users

References

• UNDCP and WHO Informal Expert Committee on the Drug-Craving Mechanism. 1992, Report, United Nations International Drug Control Programme and World Health Organization, Technical Report Series (No. V 92–54439 T)
   Google Scholar
• Pickens R W, Johanson C E. Craving: consensus of status and agenda for future research. Drug Alcohol Depend 1992; 30: 127–131
   PubMed Web of Science ®Google Scholar
• Buydens-Branchey L, Branchey M, Fergeson P, et al. Craving for cocaine in addicted users: role of serotonergic mechanisms. Am J Addict 1997; 6: 65–73
   PubMed Web of Science ®Google Scholar
• Coccaro E F. Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavior relationship. Int Clin Psychopharmacol 1992; 7: 9–12
   Google Scholar
• Spitzer R L, Williams J B, Gibbon M, et al. User's Guide for the Structured Clinical Interview of the DSM-III-R. American Psychiatric Press, Washington, DC 1990
   Google Scholar
• Murphy D L, Mueller E A, Hill J L, et al. Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-CPP given intravenously or orally to healthy volunteers. Psychopharmacology 1989; 98: 275–282
   PubMedGoogle Scholar
• Krebs H A, Cheng L K, Wright G H. Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. J Chromatogr Biochem Appl 1984; 310: 412–417
   PubMed Web of Science ®Google Scholar
• Suckow R F, Cooper T B, Kahn R S. High-performance liquid chromatographic method for the analysis of plasma m-chlorophenylpiperazine. J Chromatogr 1990; 528: 228–234
   PubMedGoogle Scholar
• Fuller R W, Snoddy H D. Effect of serotoninreleasing drugs on serum corticosterone concentration in rats. Neuroendocrinology 1980; 31: 96–100
   PubMed Web of Science ®Google Scholar
• Fuller R W. Serotonergic stimulation of pituitaryadrenocortical function in rats. Neuroendocrinology 1981; 32: 118–127
   PubMed Web of Science ®Google Scholar
• Bagdy G, Calogero A E, Murphy D L, et al. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 1989; 125: 2664–2669
   PubMed Web of Science ®Google Scholar
• Gibbs D M, Vale W. Effect of the serotonin reup-take inhibitor fluoxetine on corticotropinreleasing factor and vasopressin secretion into hypophyseal portal blood. Brain Res 1983; 280: 176–179
   PubMedGoogle Scholar
• Meltzer H Y, Maes M. Effect of pindolol pretreatment on MK212-induced plasma cortisol and prolactin responses in men. Biol Psychiatry 1995; 38: 310–318
   Google Scholar
• Hollander E, Cohen L J, De Caria C. Timing of neuroendocrine responses and effects of m-CPP and fenfluramine plasma levels in OCD. Biol Psychiatry 1993; 34: 407–413
   PubMed Web of Science ®Google Scholar
• Naranjo C A, Brenner K E. Serotonin-altering medications and desire, consumption, and effects of alcohol: treatment implications. Towards a Molecular Basis of Alcohol Use and Abuse, B Jansson, H Jörnvall, U Rydberg, et al. Birkhäuser, BaselSwitzerland 1994; 209–219
   Google Scholar
• Pollack M H, Rosenbaum J F. Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry 1991; 52: 31–33
   PubMed Web of Science ®Google Scholar
• Batki S L, Manfredi L B, Peyton J, et al. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Pharmacol 1993; 13: 243–250
   Google Scholar
• Batki S L, Washburn A M, Delucchi K, et al. A controlled trial of fluoxetine in crack-cocaine dependence. Drug Alcohol Depend 1996; 41: 137–142
   PubMed Web of Science ®Google Scholar
• Covi L, Hess J M, Kreiter N A, et al. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse 1995; 21: 327–344
   PubMed Web of Science ®Google Scholar
• Grabowski J, Rhoades H, Elk R, et al. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled, double-blind trials. J Clin Psychopharmacol 1995; 15: 163–174
   PubMed Web of Science ®Google Scholar
• Walsh S L, Preston K L, Sullivan J T, et al. Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharmacol. 1994; 14: 396–407
   PubMed Web of Science ®Google Scholar
• Howell L L, Byrd L D. Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther 1995; 275: 1550–1559
   Google Scholar
• Tiffany S T, Singleton E, Haertzer C A, et al. The development of a craving questionnaire. Drug Alcohol Depend 1993; 34: 19–28
   PubMed Web of Science ®Google Scholar
• Krystal J H, Webb E, Cooney N, et al. Specificity of ethanol-like effects elicited by serotonergic and noradrenergic mechanisms. Arch Gen Psychiatry 1994; 51: 589–911
   Google Scholar